Venus Concept Inc. (VERO)
| Market Cap | 1.49M -41.6% |
| Revenue (ttm) | 58.88M -12.4% |
| Net Income | -54.61M |
| EPS | -46.03 |
| Shares Out | 1.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 250,636 |
| Average Volume | 17,886,222 |
| Open | 1.0100 |
| Previous Close | 1.1400 |
| Day's Range | 0.7500 - 1.2400 |
| 52-Week Range | 0.7500 - 14.5000 |
| Beta | -0.07 |
| RSI | 42.27 |
| Earnings Date | Mar 27, 2026 |
About Venus Concept
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for d... [Read more]
Financial Performance
In 2024, Venus Concept's revenue was $64.83 million, a decrease of -15.09% compared to the previous year's $76.35 million. Losses were -$47.00 million, 26.2% more than in 2023.
Financial StatementsNews
Is Venus Concept Inc Gaining or Losing Market Support?
Venus Concept Inc's (NYSE: VERO) short interest as a percent of float has risen 113.17% since its last report. According to exchange reported data, there are now 199 thousand shares sold short , whic...
Why Is Venus Concept Stock Plunging Today?
Venus Concept Inc. (NASDAQ: VERO) shares fell on Wednesday after the company said it will voluntarily delist from Nasdaq and end SEC reporting . The board notified Nasdaq that it plans to leave the N...
Venus Concept (VERO) to Delist from Nasdaq, Shares Plunge
Venus Concept (VERO) to Delist from Nasdaq, Shares Plunge
Venus Concept to voluntarily delist from Nasdaq and deregister with SEC; shares tumble
Venus Concept Shares Plunge 50% On Voluntary Nasdaq Delisting Decision
(RTTNews) - Venus Concept Inc. (VERO), a global medical aesthetic technology company, announced its intention to voluntarily delist its common stock from the Nasdaq Capital Market and deregister its s...
Venus Concept (VERO) Plans to Delist from Nasdaq and Deregister with SEC
Venus Concept (VERO) Plans to Delist from Nasdaq and Deregister with SEC
Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC
TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market (“Na...
Top 3 Health Care Stocks You May Want To Dump In January
As of Jan. 20, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Venus Concept Stock Explodes Over 500% After Major Investor Takes Control
Venus Concept Inc. (NASDAQ: VERO) stock skyrocketed over 500% on Friday. • Venus Concept stock is among today’s top performers. What’s fueling VERO momentum? Trading Volume The stock is trading with ...
Venus Concept Stock Explodes Over 500% After Major Investor Takes Control
Venus Concept Inc. (NASDAQ: VERO) stock skyrocketed over 500% on Friday.
Crude Oil Gains 1%; US Industrial Output Rises In December
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 0.1% on Friday. The Dow traded down 0.09% to 49,398.52 while the NASDAQ gained 0.13% to 23,559.46. The S&P 500 ...
Why PainReform Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Shares of PainReform Ltd. (NASDAQ: PRFX) rose sharply in pre-market trading . The company announced a name change amid its expansion diversified healthcare and AI-driven energy platforms. PainReform ...
Venus Concept Inc. (VERO) Q3 2025 Earnings Call Transcript
Venus Concept Inc. ( VERO) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Rajiv Kanishka De Silva - CEO & Director Domenic Penna - Executive VP & CFO Presentation Operator G...
Venus Concept Announces Third Quarter 2025 Financial Results
TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction
Reduction of outstanding debt by Madryn Asset Management continues to improve the Company's financial position Reduction of outstanding debt by Madryn Asset Management continues to improve the Company...
Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fis...
Cellulite Treatment Market Size to Reach USD 5.19 Billion by 2032, Driven by Rising Demand for Non-Invasive Aesthetic Solutions | S&S Insider
Growing popularity of advanced cosmetic technologies, social media influence, and increasing aesthetic consciousness are fueling robust growth in the global cellulite treatment market. Growing popular...
Venus Concept Inc. (VERO) Q2 2025 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO) Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ET Company Participants Domenic Della Penna - Executive VP & CFO Rajiv Kanishka Liyanaarchchie De Silva - CEO...
Venus Concept Announces Second Quarter 2025 Financial Results
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025
TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fi...
Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction
Further reduction of outstanding debt by Madryn Asset Management improves the Company's balance sheet position Further reduction of outstanding debt by Madryn Asset Management improves the Company's b...
Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an addi...
Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an addi...
Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a def...
Venus Concept Inc. (VERO) Q1 2025 Earnings Call Transcript
Venus Concept Inc. (NASDAQ:VERO) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - CFO Conference Call Participants Thomas McGov...